Paul Howard, PhD, is an accomplished healthcare policy leader with a proven record of directing large-scale programs and high impact communications to help prepare the industry for the future of healthcare technology and precision-guided care. He leverages his policy and government experience to advance the mission of organizations driving innovation to improve patient outcomes and is recognized as an impassioned leader and effective communicator with the ability to cultivate a vision based on shared values. He is currently Executive Director, Policy and Patient Experience Innovation, at Amicus Therapeutics, where he is responsible for ensuring consistent and appropriate implementation of overarching public policy initiatives and messages within the US that help shape the legislative, reimbursement, and regulatory environment for the development and marketing of products for the treatment of rare and genomic disorders. Previously, he was Senior Advisor to the Commissioner of the U.S. Food and Drug Administration (2017-19) on regulatory policy, strategic innovation initiatives, and promoting competition to efficiently advance public health and safety. Prior to joining the U.S. FDA, he was a Senior Fellow and Director of Health Policy at the Manhattan Institute, where he testified before Congress multiple times on issues related to drug pricing, FDA modernization, and health care reform.